UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Prevalence and Clinical Significance of Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Lung Disease

Journal of Clinical Microbiology, 2007-01, Vol.45 (1), p.168-172

2007

Volltextzugriff (PDF)

Management of Helicobacter pylori infection in paediatric patients in Europe: results from the EuroPedHp Registry

Infection, 2023-08, Vol.51 (4), p.921-934

2023

Volltextzugriff (PDF)

Stimuli Generation for Quality-of-Experience Evaluation of Mobile Applications

International journal of interactive mobile technologies, 2022-03, Vol.16 (6), p.113-134

2022

Volltextzugriff (PDF)

Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA–GPGE Registry

Frontiers in pediatrics, 2022-05, Vol.10, p.875938-875938

2022

Volltextzugriff (PDF)

Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry

Deutsches Ärzteblatt international, 2015-02, Vol.112 (8), p.121-127

2015

Volltextzugriff (PDF)

Lipopolysaccharide binding protein, cytokine production in whole blood, and lipoproteins in cystic fibrosis

Pediatric research, 2005-11, Vol.58 (5), p.903-907

2005

Volltextzugriff (PDF)

Endogenous Carbon Monoxide Signaling Modulates Mitochondrial Function and Intracellular Glucose Utilization: Impact of the Heme Oxygenase Substrate Hemin

Antioxidants, 2020-08, Vol.9 (8), p.652

2020

Volltextzugriff (PDF)

Chemical in‐depth analysis of (Ca/Sr)F 2 core–shell like nanoparticles by X‐ray photoelectron spectroscopy with tunable excitation energy

Surface and interface analysis, 2021-05, Vol.53 (5), p.494-508

2021

Volltextzugriff (PDF)

Chemical in‐depth analysis of (Ca/Sr)F2 core–shell like nanoparticles by X‐ray photoelectron spectroscopy with tunable excitation energy

Surface and interface analysis, 2021-05, Vol.53 (5), p.494-508

2021

Volltextzugriff (PDF)

Incidence, Risk Factors, Treatment and Long Term Outcome of Refractory and First Relapse AML Patients in the OSHO Studies

Blood, 2019-11, Vol.134 (Supplement_1), p.1358-1358

2019

Volltextzugriff (PDF)

Imatinib (IM) in Combination with Hydroxyurea Showed Significantly Lower Major Molecular Response Rates at 6 Months but Similar MMR at 18 Months in Patients with CML1st CP Compared to IM Alone. Final Results of the CML2004 Study. NCT 02480608

Blood, 2017-12, Vol.130, p.1615-1615

2017

Volltextzugriff (PDF)

The effect of prior exposure to imatinib on transplant-related mortality

Haematologica (Roma), 2006-04, Vol.91 (4), p.452-459

2006

Volltextzugriff (PDF)

Comparison of Treatment Strategies in Patients over 60 Years with AML: Final Analysis of a Prospective Randomized German AML Intergroup Study

Blood, 2016-12, Vol.128 (22), p.1066-1066

2016

Volltextzugriff (PDF)

Prognostic Factors for Overall Survival in Relapsed Acute Myeloid Leukemia

Blood, 2014-12, Vol.124 (21), p.3666-3666

2014

Volltextzugriff (PDF)

Non-infectious ulcerating oral mucous membrane diseases

Journal der Deutschen Dermatologischen Gesellschaft, 2009-03, Vol.7 (3), p.242-257

2009

Volltextzugriff (PDF)

Nicht-infektiöse exulzerierende Mundschleimhauterkrankungen

Journal der Deutschen Dermatologischen Gesellschaft, 2009-03, Vol.7 (3), p.242-258

2009

Volltextzugriff (PDF)

Reactive hyperplasias,precancerous and malignant lesions of the oral mucosa

Journal der Deutschen Dermatologischen Gesellschaft, 2008-03, Vol.6 (3), p.217-232

2008

Volltextzugriff (PDF)

Combined Bendamustine, Prednisone and Bortezomib (BPV) in Patients with Relapsed or Refractory Multiple Myeloma

Blood, 2012-11, Vol.120 (21), p.1855-1855

2012

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

ThemaDermochelys Coriacea

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence and Clinical Significance of Staphylococcus aureus Small-Colony Variants in Cystic Fibrosis Lung Disease

Management of Helicobacter pylori infection in paediatric patients in Europe: results from the EuroPedHp Registry

Stimuli Generation for Quality-of-Experience Evaluation of Mobile Applications

Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA–GPGE Registry

Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry

Lipopolysaccharide binding protein, cytokine production in whole blood, and lipoproteins in cystic fibrosis

Endogenous Carbon Monoxide Signaling Modulates Mitochondrial Function and Intracellular Glucose Utilization: Impact of the Heme Oxygenase Substrate Hemin

Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy

Chemical in‐depth analysis of (Ca/Sr)F 2 core–shell like nanoparticles by X‐ray photoelectron spectroscopy with tunable excitation energy

Chemical in‐depth analysis of (Ca/Sr)F2 core–shell like nanoparticles by X‐ray photoelectron spectroscopy with tunable excitation energy

Incidence, Risk Factors, Treatment and Long Term Outcome of Refractory and First Relapse AML Patients in the OSHO Studies

Imatinib (IM) in Combination with Hydroxyurea Showed Significantly Lower Major Molecular Response Rates at 6 Months but Similar MMR at 18 Months in Patients with CML1st CP Compared to IM Alone. Final Results of the CML2004 Study. NCT 02480608

The effect of prior exposure to imatinib on transplant-related mortality

Hematopoietic stem cell transplantation (HSCT) compared to consolidation chemotherapy (CT) to increase leukemia free survival (LFS) in acute myelogenous leukemia (AML) patients between 60 and 75 years irrespective of genetic risk: Report from the AML 2004 of the East German Study Group (OSHO)

Comparison of Treatment Strategies in Patients over 60 Years with AML: Final Analysis of a Prospective Randomized German AML Intergroup Study

Long Term Follow up of the AML97-Study for Patients with AML Older Than 60 Years: A Study of the East German Hematology and Oncology Study Group (OSHO)

Successful Stem Cell Mobilization and Autologous Stem Cell Transplantation after Pretreatment Consisting of Bendamustine, Prednisone and Bortezomib (BPV) in 35 Patients with Newly Diagnosed/Untreated Multiple Myeloma

Higher Leukemia Free Survival after Post-Induction Hematopoietic Cell Transplantation Compared to Consolidation Therapy in Patients >60 Years with Acute Myelogenous Leukemia (AML): Report from the AML 2004 East German Study Group (OSHO)

Prognostic Factors for Overall Survival in Relapsed Acute Myeloid Leukemia

Increasing The Dose Of AraC In Consolidation Therapy Does Not Lead To Higher Overall Survival Or Improved Relapse Incidence In Patients With AML Over The Age Of 60 Years

Prognostic Factors For Overall Survival In Elderly Patients With Relapsed Acute Myeloid Leukemia – Retrospective Study On Behalf Of The East German Study Group For Hematology and Oncology (OSHO)

Non-infectious ulcerating oral mucous membrane diseases

Nicht-infektiöse exulzerierende Mundschleimhauterkrankungen

Reactive hyperplasias,precancerous and malignant lesions of the oral mucosa

Combined Bendamustine, Prednisone and Bortezomib (BPV) in Patients with Relapsed or Refractory Multiple Myeloma

Aktive Filter

Suchergebnisse filtern